David M. Mott - 30 Jun 2022 Form 4 Insider Report for Epizyme, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jul 2022, 17:06:31 UTC
Prior SEC filing
21 Jun 2022
Next SEC filing
01 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/John Weidenbruch, attorney-in-fact
Filing notes and source

Key filing fact

David M. Mott filed Form 4 for Epizyme, Inc. on 05 Jul 2022.

Key facts

  • This page summarizes David M. Mott's Form 4 filing for Epizyme, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Jul 2022, 17:06.

Change

  • Previous filing in this sequence was filed on 21 Jun 2022.
  • Current net transaction value: +$23,749.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EPZM transaction

Common Stock, par value $0.0001

Award

Transaction value
$23,749
Shares
+16,156
Change %
+7.8%
Price
$1.47
Shares after
224,488
Date
30 Jun 2022
Ownership
Direct
Footnotes
F1
EPZM holding

Common Stock, par value $0.0001

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
106,959
Date
30 Jun 2022
Ownership
See Note
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares were issued to the Reporting Person pursuant to his election under the Issuer's director compensation program to receive such shares in lieu of cash fees of $23,750 for Board services for the second fiscal quarter of 2022. The shares were issued on the last day of the second fiscal quarter and the number of shares was calculated by dividing the cash fees to be paid for the quarter by the closing price of the Issuer's common stock on the last trading day of the quarter.

Footnote F2

The shares are directly held by the David Mott Declaration of Trust dated May 31, 2001 as amended (the "Mott Trust"). The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Mott Trust shares in which the Reporting Person has no pecuniary interest.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .